Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection were released on Thursday, November 1, 2012. Please send your comments to ContactUs@aidsinfo.nih.gov by November 15, 2012.
Corrections were made to the guideline. For a description of the changes, please see the correction notice.
(Last updated:11/1/2012; last reviewed:11/1/2012)
Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus
Lipodystrophy, Lipohypertrophy, Lipoatrophy
Osteopenia, Osteoporosis, Osteonecrosis
Peripheral Nervous System Toxicity
Skin Rash, SJS/EM/TEN, HSR